Ethical Issues in Oncogeriatrics in Tunisia

##plugins.themes.academic_pro.article.sidebar##

Published May 24, 2026
https://doi.org/10.62438/tunismed.v104i05.6215
Download
PDF
Vol. 104 No. 05 (2026): Tunis Med May 2026

##plugins.themes.academic_pro.article.main##

Imen Akkari
Gastroenterology Department, Farhat-Hached University Hospital, Faculty of Medicine of Sousse, Rue Mohamed Karoui, University of Sousse, Sousse 4000, Tunisia

Abstract

Background: Oncogeriatrics is a sensitive medical specialty dealing with malignant neoplastic diseases in elderly patients. Ethical challenges have emerged due to both the specific characteristics of the affected population and the severity of the disease.
Aim: To report and analyze the ethical issues raised in oncogeriatrics.
Results: Oncogeriatrics is an emerging specialty that has developed in response to two major epidemiological observations: the aging population and the increasing number of cancer patients. Assessing these patients using specific scoring tools is essential to identify their particular needs.
The unique characteristics of this population give rise to several ethical dilemmas, including end-of-life issues (such as therapeutic obstinacy and euthanasia) and those related to the patient’s capacity for discernment and informed consent. The main ethical concerns discussed in this paper
include access to care, research, consent and the right to information, and end-of-life issues. Addressing these challenges involves applying the four fundamental principles of medical ethics: respect for autonomy, non-maleficence, beneficence, and justice.
Conclusion: Adhering to the four principles of ethics provides a framework for managing ethical issues. However, in oncogeriatrics, applying these principles must be carefully evaluated due to the specific characteristics of the elderly population.

Keywords:

oncology , geriatric , ethic

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Falandry C, Filbet M, Magnet M, Trillet-Lenoir V, Bonnefoy M. Oncogériatrie : quelle réalité aujourd’hui ? Médecine Palliative :
  2. Soins de Support - Accompagnement - Éthique. 2011;10(5):223-9.
  3. Oncogériatrie - L’organisation de l’offre de soins [Internet]. [cité 31 mai 2023]. Disponible sur: https://www.e-cancer.fr/Professionnels-
  4. de-sante/L-organisation-de-l-offre-de-soins/Oncogeriatrie
  5. Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018 - Tumeurs solides : Étude
  6. à partir des registres des cancers du réseau Francim [Internet]. [cité 24 mars 2023]. Disponible sur: https://www.santepubliquefrance.
  7. fr/maladies-et-traumatismes/cancers/cancer-du-sein/documents/ rapport-synthese/estimations-nationales-de-l-incidence-et-de-
  8. la-mortalite-par-cancer-en-france-metropolitaine-entre-1990-et-2018-volume-1-tumeurs-solides-etud
  9. Lichtman SM, Wildiers H, Launay-Vacher V, Steer C, Chatelut E, Aapro M. International Society of Geriatric Oncology (SIOG)
  10. recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. European Journal of Cancer
  11. .2007;43(1):14-34.
  12. Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz JP, Lichtman S, et al. Use of comprehensive geriatric assessment in older cancer
  13. patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol
  14. Hematol. 2005;55(3):241-52.
  15. Davies E, Higginson IJ. Better palliative care for older people [Internet]. World Health Organization. Regional Office for Europe;
  16. [cité 3 avr 2023]. 40 p. Disponible sur: https://apps.who.int/iris/handle/10665/107563
  17. Decretdeontologiemedicale93.pdf [Internet]. [cité 8 avr 2023]. Disponible sur: http://www.atds.org.tn/
  18. Decretdeontologiemedicale93.pdf
  19. Whelehan S, Lynch O, Treacy N, Gleeson C, Oates A, O’Donovan A. Optimising Clinical Trial Design in Older Cancer Patients. Geriatrics.
  20. ;3(3):34.
  21. Fang P, He W, Gomez DR, Hoffman KE, Smith BD, Giordano SH, et al. Influence of Age on Guideline-Concordant Cancer Care for
  22. Elderly Patients in the United States. Int J Radiat Oncol Biol Phys. 2017;98(4):748-57.
  23. Brain E, Girre V, Rigal O, Abadie-Lacourtoisie S, Uwer L, Bourbouloux E. Screening success and inclusion failure rates in a prospective trial
  24. of adjuvant chemotherapy for breast cancer in elderly women by the french geriatric oncology group GERICO. Ann Oncol. 2010; 21:186.
  25. Boyle H, Girre V, Mertens C, Falandry C, Gouttenoire F, Freyer G, et al. Recherche clinique en oncogériatrie. Oncologie.2009; 11:331–336
  26. FMC-HGE [Internet]. [cité 6 avr 2023]. Apports et limites de la consultation d’oncogériatrie. Disponible sur: https://www.
  27. fmcgastro.org/textes-postus/no-postu_year/apports-et-limites-de-la-consultation-doncogeriatrie/
  28. WMA - The World Medical Association-Manuel D’éthique Médicale [Internet]. [cité 29 mars 2023]. Disponible sur: https://www.
  29. wma.net/fr/ce-que-nous-faisons/education/manuel-dethique-medicale/
  30. Retornaz F, Potard I, Molines C, Rousseau F. Critères de fragilité appliqués en oncogériatrie. cah année gerontol. Cah. Année
  31. Gérontol. (2011); 3:20-25
  32. Boyer A, Eon B, Quentin B, Blondiaux I, Bordet F, Dray S, et al. Que change la Loi Claeys-Leonetti pour les réanimateurs ? Réanimation.
  33. ;25(4):419-25.
  34. D, Sun CL, at all. Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-RelatedToxic Effects in Older Adults With Cancer: A
  35. Randomized Clinical Trial. JAMA Oncol. 2021 Nov1;7(11):e214158. doi: 10.1001/jamaoncol.2021.4158. Epub 2021 Nov 18.